SMITH MARK ALAN (CHIEF MEDICAL OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2022ACC: 0001415889-22-000046
Officer· CHIEF MEDICAL OFFICER
Since Aug 2018
+2.65K
Net shares
Net buyer
$4.4K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.65K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.65K
Price / share
$1.66
Trade value
$4.40K
% of position
21.7%
12/31/2021
12.26K→14.91K
Total
Net shares
+2.65K
Net value
$4.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2021 | A · Award | +2.65K | $1.66 | $4.40K | 21.7% | 12.26K | 14.91K |
| Total | +2.65K | $4.40K | ||||||
Derivative Transactions0
No derivative transactions reported